Medical Composites Global Market Report 2024

Medical composites refer to a combination of two or more materials with distinct physical and chemical properties. These composites find applications in various medical fields, including diagnostic imaging, biological resurfacing of damaged areas, surgical applications, and dental implants.

The main types of medical composites include carbon fiber, ceramic fiber, and other fiber types. Ceramic fibers are small-dimension filaments or threads composed of ceramic materials, typically alumina and silica, and are utilized in lightweight units for electrical, thermal, and sound insulation. The processes involved in creating medical composites include wet lamination, prepreg, and other manufacturing methods. These composites are applied in diagnostic imaging, composite body implants, surgical instruments, dental applications, and other contexts.

The medical composites market research report is one of a series of new reports that provides medical composites market statistics, including medical composites industry global market size, regional shares, competitors with a medical composites market share, detailed medical composites market segments, market trends and opportunities, and any further data you may need to thrive in the medical composites industry. This medical composites market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical composites market size has grown rapidly in recent years. It will grow from $1.3 billion in 2023 to $1.47 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The expansion observed in the historical period can be attributed to several factors, including the increased use of medical composites in orthopedic applications, the impact of an aging population leading to a rise in healthcare needs, the application of composites in trauma and sports injury treatment, compliance with regulatory standards, and the growing emphasis on patient-centric care.

The medical composites market size is expected to see rapid growth in the next few years. It will grow to $2.45 billion in 2028 at a compound annual growth rate (CAGR) of 13.6%. The projected growth in the forecast period can be attributed to various factors, including the adoption of personalized implants, the advancement of additive manufacturing technologies, the increasing prevalence of telehealth services, the development of regenerative medicine approaches, and the use of biocompatible nanocomposites in medical applications. Key trends expected in this period include the utilization of customized 3D-printed implants, the implementation of remote monitoring solutions, the integration of smart composite materials, a focus on sustainability and eco-friendly materials, and the incorporation of wearable health devices.

The anticipated rise in demand for medical composites within the healthcare sector is poised to drive the growth of the medical composites market. The healthcare sector encompasses entities providing medical services, developing medical devices and medications, and offering medical insurance. The increasing need for medical instruments is contributing to the growing demand for medical composites in the healthcare sector. Notably, in Europe, approximately 11% of the gross domestic product (GDP) is allocated to healthcare, with around 7.6% attributed to medical technologies, according to MedTech Europe, a Belgium-based European trade association. The expenditure on medical technology across European countries ranges from 5% to 12% of total healthcare expenditure, with per capita spending on medical technology in Europe standing at around $346.08 (€284). Thus, the escalating demand for medical composites from the healthcare sector is a significant driver of the medical composites market.

The increasing prevalence of breast cancer is expected to further propel the growth of the medical composites market. Breast cancer, characterized by a malignant tumor originating in breast cells, necessitates advanced materials for the creation of lightweight, personalized radiation therapy devices and implants. This enhances patient comfort and improves treatment effectiveness. According to the Centers for Disease Control and Prevention (CDC), each year in the United States, approximately 240,000 women and 2,100 men receive breast cancer diagnoses, with about 42,000 women and 500 men succumbing to the disease annually. Therefore, the rising incidence of breast cancer is a significant factor driving the growth of the medical composites market.

A noteworthy trend in the medical composites market is the focus on technological advancements. Major companies operating in this market are actively developing new technological solutions to bolster their positions. For example, in February 2022, Nobio, an Israel-based company in the medical composites sector, introduced Infinix, an innovative collection of advanced antimicrobial restorative materials designed to combat recurrent deterioration. Nobio's QASi antimicrobial particle technology, a part of the infinix system, is utilized in universal and flowable composites and the universal bonding system. These new restorative materials with QASi antimicrobial particle technology are employed to prevent tooth demineralization, offering long-lasting bacterial inhibition at restorative margins and reducing restoration failure due to secondary caries.

Major players in the medical composites market are intensifying their focus on introducing high-performance polymers, such as Magnolia Trinity PEEK, to gain a competitive edge. Magnolia Trinity PEEK, a medical-grade PEEK composite composed of three clinically proven biomaterials, was launched by Superior Polymers, a US-based polymer company, in October 2023. This composite, suitable for implantable medical devices in contact with bodily fluids or tissue for more than 24 hours, presents an appealing option for medical device manufacturers due to its superior performance in terms of strength, stiffness, and durability.

In June 2021, The Gund Company Inc., a USA-based manufacturing company specializing in engineered material solutions, acquired Power & Composite Technologies, LLC, a US-based company operating in medical composites, for an undisclosed amount. This strategic acquisition is expected to expand The Gund Company's product portfolio in medical composites and material solutions for medical devices.

Major companies operating in the medical composites market include 3M Company, Toray Industries Inc., SGL Carbon SE, CeramTec GmbH, Composiflex Inc., Dentsply Sirona Inc., Mitsubishi Chemical Holdings Corporation, Avient Corporation, Zeus Industrial Products Inc., Kulzer GmbH, Kaman Corporation, Den-Mat Holdings LLC, Ivoclar Vivadent Inc., Tokuyama Dental Corporation Inc., Quantum Composites Inc., Teijin Limited, Dental Technologies Inc., Koninklijke DSM N.V., Fillauer LLC, Getinge Group, Hill-Rom Holdings Inc., icotec AG, Johns Manville Corp., Nippon Sheet Glass Co. Ltd., Ossur, Ottobock SE & Co. KGaA, Owens Corning, Park Aerospace Corp., Shofu Inc., Taishan Fibreglass South Africa (Pty) Ltd., Fiber Materials Inc., Stryker Corporation

North America was the largest region in the medical composites market in 2023. The regions covered in this medical composites share market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the medical composites market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The medical composites market consists of sales of polymer matrix composites, carbon matrix composites, metal matrix composites, and ceramic matrix composites. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.